Javascript must be enabled to continue!
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis
View through CrossRef
Abstract
Background
In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged with a high transmissibility rate and resulted in numerous negative impacts on global life. Preventive measures such as facial masks, social distancing, and vaccination helped control the pandemic. Nonetheless, the emergence of SARS-CoV-2 variants, such as Omega and Delta, as well as coronavirus disease 2019 (COVID-19) reinfection, raise additional concerns. Therefore, this study aimed to determine the overall prevalence of reinfection on global and regional scales.
Methods
A systematic search was conducted across three databases, PubMed, Scopus, and ProQuest Central, including all articles pertaining to COVID-19 reinfection without language restriction. After critical appraisal and qualitative synthesis of the identified relevant articles, a meta-analysis considering random effects was used to pool the studies.
Results
We included 52 studies conducted between 2019 and 2022, with a total sample size of 3,623,655 patients. The overall prevalence of COVID-19 reinfection was 4.2% (95% confidence interval [CI]: 3.7–4.8%; n = 52), with high heterogeneity between studies. Africa had the highest prevalence of 4.7% (95% CI: 1.9–7.5%; n = 3), whereas Oceania and America had lower estimates of 0.3% (95% CI: 0.2–0.4%; n = 1) and 1% (95% CI: 0.8–1.3%; n = 7), respectively. The prevalence of reinfection in Europe and Asia was 1.2% (95% CI: 0.8–1.5%; n = 8) and 3.8% (95% CI: 3.4–4.3%; n = 43), respectively. Studies that used a combined type of specimen had the highest prevalence of 7.6% (95% CI: 5.8–9.5%; n = 15) compared with those that used oropharyngeal or nasopharyngeal swabs only that had lower estimates of 6.7% (95% CI: 4.8–8.5%; n = 8), and 3.4% (95% CI: 2.8–4.0%; n = 12) respectively.
Conclusion
COVID-19 reinfection occurs with varying prevalence worldwide, with the highest occurring in Africa. Therefore, preventive measures, including vaccination, should be emphasized to ensure control of the pandemic.
Research Square Platform LLC
Title: Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis
Description:
Abstract
Background
In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged with a high transmissibility rate and resulted in numerous negative impacts on global life.
Preventive measures such as facial masks, social distancing, and vaccination helped control the pandemic.
Nonetheless, the emergence of SARS-CoV-2 variants, such as Omega and Delta, as well as coronavirus disease 2019 (COVID-19) reinfection, raise additional concerns.
Therefore, this study aimed to determine the overall prevalence of reinfection on global and regional scales.
Methods
A systematic search was conducted across three databases, PubMed, Scopus, and ProQuest Central, including all articles pertaining to COVID-19 reinfection without language restriction.
After critical appraisal and qualitative synthesis of the identified relevant articles, a meta-analysis considering random effects was used to pool the studies.
Results
We included 52 studies conducted between 2019 and 2022, with a total sample size of 3,623,655 patients.
The overall prevalence of COVID-19 reinfection was 4.
2% (95% confidence interval [CI]: 3.
7–4.
8%; n = 52), with high heterogeneity between studies.
Africa had the highest prevalence of 4.
7% (95% CI: 1.
9–7.
5%; n = 3), whereas Oceania and America had lower estimates of 0.
3% (95% CI: 0.
2–0.
4%; n = 1) and 1% (95% CI: 0.
8–1.
3%; n = 7), respectively.
The prevalence of reinfection in Europe and Asia was 1.
2% (95% CI: 0.
8–1.
5%; n = 8) and 3.
8% (95% CI: 3.
4–4.
3%; n = 43), respectively.
Studies that used a combined type of specimen had the highest prevalence of 7.
6% (95% CI: 5.
8–9.
5%; n = 15) compared with those that used oropharyngeal or nasopharyngeal swabs only that had lower estimates of 6.
7% (95% CI: 4.
8–8.
5%; n = 8), and 3.
4% (95% CI: 2.
8–4.
0%; n = 12) respectively.
Conclusion
COVID-19 reinfection occurs with varying prevalence worldwide, with the highest occurring in Africa.
Therefore, preventive measures, including vaccination, should be emphasized to ensure control of the pandemic.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Timing of device reimplantation and reinfection rates following cardiac implantable electronic device infection: a systematic review and meta-analysis
Timing of device reimplantation and reinfection rates following cardiac implantable electronic device infection: a systematic review and meta-analysis
ObjectivesInitial management of cardiac implantable electronic device (CIED) infection requires removal of the infected CIED system and treatment with systemic antibiotics. However...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
Outcomes of SARS-CoV-2 Reinfection
Outcomes of SARS-CoV-2 Reinfection
Abstract
First infection with SARS-CoV-2 is associated with increased risk of acute and post-acute death and sequelae in the pulmonary and extrapulmonary organ systems. How...
COVID-19 reinfection in Afghanistan: A descriptive analysis of data from DHIS2, 2022
COVID-19 reinfection in Afghanistan: A descriptive analysis of data from DHIS2, 2022
Background: Despite millions of COVID-19 infections worldwide since the beginning of the pandemic, relatively few confirmed cases of COVID-19 reinfection have been reported. In Afg...
Recurrence Possibility of COVID-19 in India
Recurrence Possibility of COVID-19 in India
Although nationwide lockdown was imposed in India amid COVID-19 outbreak since March 24, 2020, the COVID-19 infection is increasing day-by-day. India became world’s second most aff...
COVID-19 reinfection
COVID-19 reinfection
INTRODUCTION:
There are limited direct data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) long-term immune responses and reinfection. This study aimed...

